These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3824918)

  • 1. [Does verapamil affect the thickness of the cardiac muscle in hypertrophic cardiomyopathy?].
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Vnitr Lek; 1986 Dec; 32(12):1188-96. PubMed ID: 3824918
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of verapamil on the left ventricular function in hypertrophic obstructive cardiomyopathy].
    Guo HS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Mar; 12(1):13-6. PubMed ID: 6540163
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term treatment of hypertrophic non obstructive cardiomyopathy (HNCM) with verapamil (author's transl)].
    Kuhn H; Thelen U; Leuner C; Köhler E; Bluschke V
    Z Kardiol; 1980 Oct; 69(10):669-75. PubMed ID: 7192910
    [No Abstract]   [Full Text] [Related]  

  • 4. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy.
    Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE
    Clin Invest Med; 1980; 3(1-2):195-203. PubMed ID: 7009000
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypertrophic occlusive cardiomyopathy.
    Kaltenbach M; Hopf R
    Clin Invest Med; 1980; 3(1-2):179-84. PubMed ID: 7008998
    [No Abstract]   [Full Text] [Related]  

  • 6. [Myocardial hypertrophy: regression in hypertrophic cardiomyopathies?].
    Kuhn H
    Z Kardiol; 1985; 74 Suppl 7():179-85. PubMed ID: 4090586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reduction of coronary artery cross section during conservative therapy of hypertrophic obstructive cardiomyopathy].
    Kaltenbach M; Hopf R; Petersen Y; Kober G
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():358-9. PubMed ID: 565994
    [No Abstract]   [Full Text] [Related]  

  • 8. [Echocardiographic parameters in hypertrophic cardiomyopathy during verapamil treatment (author's transl].
    Lemke R; Hopf R; Kober G; Kaltenbach M
    Z Kardiol; 1980 Oct; 69(10):661-8. PubMed ID: 7192909
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of hypertrophic obstructive cardiomyopathy with verapamil.
    Kaltenbach M; Hopf R; Kober G; Bussmann WD; Keller M; Petersen Y
    Br Heart J; 1979 Jul; 42(1):35-42. PubMed ID: 573129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of verapamil on left ventricular function in patients with hypertrophic cardiomyopathy].
    Zhao ZL
    Zhonghua Nei Ke Za Zhi; 1983 Jul; 22(7):439-41. PubMed ID: 6685611
    [No Abstract]   [Full Text] [Related]  

  • 11. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
    Crittin J; Mayor C; Bloch A
    Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of verapamil in the treatment of hypertrophic cardiomyopathy.
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Cor Vasa; 1986; 28(6):404-12. PubMed ID: 3829686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Left ventricular relaxation in hypertrophic cardiomyopathy and possibilities of controlling it with verapamil].
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Cas Lek Cesk; 1987 Mar; 126(11):330-4. PubMed ID: 3829106
    [No Abstract]   [Full Text] [Related]  

  • 14. Idiopathic hypertrophic subaortic stenosis.
    Arbogast RC; White RS
    Am Fam Physician; 1981 Jul; 24(1):97-101. PubMed ID: 7196144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic cardiomyopathy: an overview.
    Epstein SE; Maron BJ
    Clin Invest Med; 1980; 3(1-2):185-93. PubMed ID: 7008999
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic evaluation of pindolol and verapamil in hypertrophic obstructive cardiomyopathy.
    Masini V; Ceci V; Malinconico U; Milazzotto F
    G Ital Cardiol; 1981; 11(11):1729-37. PubMed ID: 7044864
    [No Abstract]   [Full Text] [Related]  

  • 17. Verapamil. A new class of antiarrhythmic agents with a variety of beneficial cardiovascular effects.
    Talano JV; Feerst D
    Arch Intern Med; 1980 Mar; 140(3):314-5. PubMed ID: 7189109
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and hemodynamic effects of verapamil in hypertrophic obstructive cardiomyopathy].
    Lösse B; Kuhn H; Loogen F
    Z Kardiol; 1982 Dec; 71(12):813-9. PubMed ID: 6891873
    [No Abstract]   [Full Text] [Related]  

  • 19. [Conservative medical treatment of hypertrophic myocardiopathies].
    Kaltenbach M; Hopf R
    Z Kardiol; 1982 Dec; 71(12):795-805. PubMed ID: 6891871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Personal experience with the long-term administration of verapamil in hypertrophic cardiomyopathies].
    Gregor P; Widimský P; Cervenka V; Vísek V; Dvorák J; Sládková T
    Vnitr Lek; 1986 Dec; 32(12):1179-87. PubMed ID: 3824917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.